Preclinical tumour models

Cell-Derived Xenografts Syngeneic mice tumour models Original preclinical resistant tumour models Patient-Derived Xenografts

Preclinical tumour models

Patient-Derived Xenografts

Cell-Derived Xenografts
Syngeneic mice tumour models
Original preclinical resistant tumour models
Patient-Derived Xenografts

© Antineo 2018

To learn more about our offer of PDX, please contact us.

ANTINEO
Faculté de Médecine Rockefeller
8, av Rockefeller
69008 LYON
FRANCE

Tel. +33 426 688 201

contact@antineo.fr

Leave your message

Preclinical services in oncology in vitro preclinical services Preclinical development of immunotherapies Preclinical development in vitro end point studies In vitro cytotoxicity In vitro synergy assays Cell cycle, proliferation, apoptosis Multiple colour flow cytometry Immunology and Immuno-Oncology Preclinical tumour models Resistant preclinical tumor models Preclinical Development in vitro continuous-monitoring studies xCELLigence IncuCyte Sample Characterisation Multiple colour flow cytometry Molecular Biology High throughput sequencing ex vivo preclinical services in vivo preclinical services Preclinical non-reglementary toxicity Preclinical non-reglementary pharmacokinetics Preclinical tumour models Resistant preclinical tumour models Preclinical in vivo efficacy studies Tumour and organ sampling Preclinical development of immunotherapies Immunology and Immuno-oncology Antibody dependant mechanisms in vivo ADCC assay in vivo CDC assay in vivo efficacy study for bispecific antibodies Preclinical tumour models Cell-Derived Xenografts Liquid tumours preclinical xenograft models Solid tumours preclinical xenograft models Syngeneic mice tumour models Solid tumours preclinical syngeneic models Liquid tumours preclinical syngeneic models Original preclinical resistant tumour models Patient-Derived Xenografts About Us Antineo Our Team Our scientific commitee Mission and Vision Our strengths Facilities and ressources Scientific and medical environment Equipment Network Contact News

More

T cell activation

Legals & Credits

Credits
Legals

About Us
Preclinical services in oncology
Preclinical tumour models
Our strengths
Contact
News
Publications